Recursion Pharmaceuticals Inc (RXRX)
8.20
+0.08
(+0.99%)
USD |
NASDAQ |
Apr 29, 16:00
8.21
+0.01
(+0.12%)
After-Hours: 04:16
Recursion Pharmaceuticals Profit Margin (Quarterly): -875.3% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -875.3% |
| September 30, 2023 | -920.8% |
| June 30, 2023 | -696.5% |
| March 31, 2023 | -538.4% |
| December 31, 2022 | -420.4% |
| September 30, 2022 | -463.1% |
| June 30, 2022 | -856.7% |
| Date | Value |
|---|---|
| March 31, 2022 | -1.06K% |
| December 31, 2021 | -2.60K% |
| September 30, 2021 | -1.90K% |
| June 30, 2021 | -1.74K% |
| March 31, 2021 | -1.23K% |
| December 31, 2020 | -1.01K% |
| September 30, 2020 | -2.77K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.77K%
Minimum
Sep 2020
-420.4%
Maximum
Dec 2022
-1.22K%
Average
-965.4%
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 23.41% |
| Palatin Technologies Inc | -385.6% |
| Oragenics Inc | -- |
| Actinium Pharmaceuticals Inc | -11.51K% |
| Marinus Pharmaceuticals Inc | -580.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -71.74% |
| Return on Assets | -50.01% |
| Return on Invested Capital | -71.52% |
| Gross Profit Margin (Quarterly) | 6.99% |
| Operating Margin (Quarterly) | -931.2% |
| Return on Net Operating Assets | -179.5% |